Arrivent Biopharma, Inc.
AVBP
Revenue
0.00
0.000.00%
-Assets
269.51M
▲54.01M▲25.06%
3 Months ChangeLiabilities
19.64M
▲6.68M▲51.59%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-09
Form 8-K
ID: 0001104659-24-098059
2024-08-14
Form 10-Q
ID: 0001558370-24-012236
2024-08-14
Form 8-K
ID: 0001558370-24-012223
2024-06-05
Form 8-K
ID: 0001104659-24-068503
2024-05-16
Form 8-K
ID: 0001104659-24-062528
2024-05-08
Form 10-Q
ID: 0001558370-24-007197
2024-05-08
Form 8-K
ID: 0001558370-24-007196
2024-04-22
Form 8-K
ID: 0001104659-24-049988
2024-03-28
Form 8-K
ID: 0001104659-24-040532
2024-01-30
Form 8-K
ID: 0001104659-24-008228